Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
Mayo Clin Proc
.
2020 Dec;95(12):2801-2802.
doi: 10.1016/j.mayocp.2020.09.033.
Epub 2020 Oct 1.
Author
Youssef M K Farag
1
Affiliation
1
Akebia Therapeutics, Inc., Cambridge, MA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
PMID:
33276848
PMCID:
PMC7528833
DOI:
10.1016/j.mayocp.2020.09.033
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Component Transfusion
COVID-19 Serotherapy
COVID-19* / therapy
Coronavirus Infections* / epidemiology
Humans
Immunization, Passive
Pandemics
Plasma
SARS-CoV-2